Cingulate, Inc. (CING)
5.935
-0.16
(-2.55%)
USD |
NASDAQ |
Feb 24, 10:03
Cingulate Market Cap : 44.19M for Feb. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.225B |
| Alnylam Pharmaceuticals, Inc. | 43.84B |
| Savara, Inc. | 1.190B |
| BioMarin Pharmaceutical, Inc. | 11.94B |
| Imunon, Inc. | 6.769M |
Market Cap Related Metrics
| Price to Book Value | 12.72 |
| Price | 5.935 |
| Earnings Yield | -89.09% |